Variant report
Variant | nsv521843 |
---|---|
Chromosome Location | chr16:12721521-12728587 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12444643 | chr16:12721521-12721522 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs568329274 | chr16:12721527-12721528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7185835 | chr16:12721529-12721530 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs145410556 | chr16:12721537-12721538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114750276 | chr16:12721544-12721545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534732456 | chr16:12721545-12721546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554299292 | chr16:12721574-12721575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11396821 | chr16:12721582-12721583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10600417 | chr16:12721583-12721584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200057972 | chr16:12721584-12721585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs201596083 | chr16:12721585-12721586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs397976860 | chr16:12721589-12721590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577953687 | chr16:12721603-12721604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558759998 | chr16:12721606-12721607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543601601 | chr16:12721610-12721611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184610339 | chr16:12721623-12721624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116521859 | chr16:12721633-12721634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554852235 | chr16:12721634-12721635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574745562 | chr16:12721645-12721646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186826525 | chr16:12721646-12721647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560357215 | chr16:12721650-12721651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191244262 | chr16:12721656-12721657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs151058531 | chr16:12721662-12721663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562416453 | chr16:12721673-12721674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183772155 | chr16:12721680-12721681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs117939443 | chr16:12721690-12721691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189594857 | chr16:12721691-12721692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs377496789 | chr16:12721701-12721702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559204152 | chr16:12721703-12721704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs116359817 | chr16:12721705-12721706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570686111 | chr16:12721716-12721717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113047586 | chr16:12721724-12721725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552656430 | chr16:12721725-12721726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs80229491 | chr16:12721733-12721734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538241985 | chr16:12721739-12721740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10563674 | chr16:12721759-12721760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372717946 | chr16:12721764-12721765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554590843 | chr16:12721765-12721766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574484529 | chr16:12721781-12721782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs114001704 | chr16:12721793-12721794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112126924 | chr16:12721817-12721818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs117586749 | chr16:12721822-12721823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs149718116 | chr16:12721828-12721829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs73520102 | chr16:12721836-12721837 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs185369782 | chr16:12721841-12721842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575773399 | chr16:12721847-12721848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372989357 | chr16:12721848-12721849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550894673 | chr16:12721852-12721853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs140373159 | chr16:12721856-12721857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561699339 | chr16:12721867-12721868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 17603634 | CNVD |
Hodgkin''s lymphoma | 20651079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 22566537 | CNVD |
Intellectual disability | 22566537 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Lung cancer | 18438408 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22102821 | CNVD |
Autism | 22495311 | CNVD |
idiopathic generalized epilepsy | 19843651 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Intellectual disability | 22102821 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Prostate cancer | 18632612 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 19786961 | CNVD |
Mental retardation | 19786961 | CNVD |
Schizophrenia | 19786961 | CNVD |
Mental retardation | 19951919 | CNVD |
Autism | 18791038 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Autism | 17480035 | CNVD |
Schizophrenia | 19955444 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 17847001 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:12721200-12723600 | Enhancers | A549 | lung |
2 | chr16:12721800-12723200 | Enhancers | HUVEC | blood vessel |
3 | chr16:12722200-12723000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr16:12723600-12724400 | Enhancers | HepG2 | liver |
5 | chr16:12724400-12734800 | Weak transcription | HepG2 | liver |
6 | chr16:12724800-12725000 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |